Pasireotide

Pasireotide (SOM230), a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide can suppress GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing's disease. Pasireotide also exhibits antisecretory, antiproliferative, and proapoptotic activity.
Read more
€0.00 (tax incl.)
Reference:
HY-16381
Product Details
HY-16381

Data sheet

Size
Multiple sizes
Reactivity
Somatostatin Receptor
Application
Metabolism-sugar/lipid metabolism
CAS
396091-73-9

Menu

Settings